Atropine Sulfate Injection
Product Images NDC 51662-1619

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 51662-1619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch (51662 1619 2 Pouch Label)

Atropine sulfate injection is a medication used to treat certain types of irregular heartbeats and to reduce salivation and mucus secretion during surgery. It is available in a vial containing 8mg/20mL. The cost is €0.4mg/nL. The dosage should be administered under medical supervision only with a recommended pH of 5.5. The provided code "ioc: 560z 1are 2" and "RXONLY" indicate the storage and prescribing information.*

FDA Label Image

Case (51662 1619 3 Case Label)

Atropine sulfate injection is a medication available in a 20mL vial containing 8ng/20nL (or €0.4ng/mL) of the injection. This comes in a case of 10 vials meant for medical use only and requires a prescription (Rx Only). The remaining characters such as "Vo s1eez" and "16193" are not readable and do not provide useful information.*

FDA Label Image

Rfid (51662 1619 3 Serialized Rfid Label)

FDA Label Image

D1 (D 1)

FDA Label Image

D Inter (Drug Inter)

Atropine Sulfate Injection was found to slow down the absorption of mexiletine but did not affect its oral bioavailability. The combination of atropine and intravenous metoclopramide during pre-anesthesia treatment reversed the delayed absorption of mexiletine.*

FDA Label Image

Structure (Structure)

Not available. It seems to be a combination of mathematical symbols that do not form a coherent description.*

FDA Label Image

Specific Pop (Use In Specific)

Atropine Sulfate Injection is a medication whose safety for pregnant women is not yet confirmed due to limited available data. Without proper medical attention, there are associated risks to the mother and fetus from severe or life-threatening muscarinic events. Furthermore, there are no animal reproduction studies to inform the safety of this medication for pregnant women.*

FDA Label Image

Vial (Vial Label)

This is a description of a medication with the NDC code 0641-6251-01 containing Atropine sulfate. It is intended for injection through various routes such as Intravenous, Intramuscular, Subcutaneous, Intraosseous, or Endofracheal use. The medication comes in a 20ml multi-dose vial and should be stored at 25°C and discarded within 24 hours. The manufacturer is Hikma and the address is mentioned as Berely Helghts, W 0722.*

FDA Label Image

D2 (D 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.